Guardian Pharmacy Services, Inc. Accounts Receivable, Credit Loss Expense (Reversal)
Guardian Pharmacy Services, Inc. (GRDN) reported Accounts Receivable, Credit Loss Expense (Reversal) of $2.84 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ProvisionForDoubtfulAccounts · last filed 2026-08-06
- Guardian Pharmacy Services, Inc. accounts receivable, credit loss expense (reversal) for the quarter ending 2026-06-30 was $1.78M, a 76.79% increase year-over-year.
- Guardian Pharmacy Services, Inc. accounts receivable, credit loss expense (reversal) for the quarter ending 2026-03-31 was $1.06M, a 18.53% increase year-over-year.
- Guardian Pharmacy Services, Inc. accounts receivable, credit loss expense (reversal) for the quarter ending 2025-12-31 was $1.47M, a 30.94% decline year-over-year.
- Guardian Pharmacy Services, Inc. accounts receivable, credit loss expense (reversal) for the quarter ending 2025-09-30 was $1.21M, a 8.94% increase year-over-year.
- Guardian Pharmacy Services, Inc. accounts receivable, credit loss expense (reversal) for fiscal 2025 was $4.58M, a 28.08% decline from fiscal 2024.
- Guardian Pharmacy Services, Inc. accounts receivable, credit loss expense (reversal) for fiscal 2024 was $6.37M.
| Period end | Accounts Receivable, Credit Loss Expense (Reversal) 3 month | Accounts Receivable, Credit Loss Expense (Reversal) 6 month | Accounts Receivable, Credit Loss Expense (Reversal) 9 month | Accounts Receivable, Credit Loss Expense (Reversal) 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.78M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $2.84M 10-Q · filed 2026-08-06 | $4.32M derived: sum of 3 quarters · filed 2026-08-06 | $5.52M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $1.06M 10-Q · filed 2026-05-06 | $2.53M derived: sum of 2 quarters · filed 2026-05-06 | $3.74M derived: sum of 3 quarters · filed 2026-05-06 | $4.75M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $1.47M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-11 | $2.68M derived: sum of 2 quarters · filed 2026-03-11 | $3.69M derived: sum of 3 quarters · filed 2026-08-06 | $4.58M 10-K · filed 2026-03-11 |
| 2025-09-30 | $1.21M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $2.21M derived: sum of 2 quarters · filed 2026-08-06 | $3.11M 10-Q · filed 2025-11-10 | $5.24M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $1.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $1.90M 10-Q · filed 2026-08-06 | $4.03M derived: sum of 3 quarters · filed 2026-08-06 | $5.14M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $896.00K 10-Q · filed 2026-05-06 | $3.03M derived: sum of 2 quarters · filed 2026-05-06 | $4.13M derived: sum of 3 quarters · filed 2026-05-06 | $5.87M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $2.13M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-11 | $3.24M derived: sum of 2 quarters · filed 2026-03-11 | $4.97M derived: sum of 3 quarters · filed 2026-03-11 | $6.37M 10-K · filed 2026-03-11 |
| 2024-09-30 | $1.11M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $2.85M derived: sum of 2 quarters · filed 2025-11-10 | $4.24M 10-Q · filed 2025-11-10 | |
| 2024-06-30 | $1.74M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | $3.13M 10-Q · filed 2025-08-11 | ||
| 2024-03-31 | $1.40M 10-Q · filed 2025-05-12 | |||
| 2023-09-30 | $3.71M 10-Q · filed 2024-11-12 |